Summary
Eighteen studies on Selective Decontamination of the Digestive Tract (SDD) have been published up to now. A statistically significant reduction of infection rate was found in fourteen out of the fifteen controlled studies. Although all the studies were designed to evaluate infection-related morbidity as the end point, ten centres have reported fatality rates. Six centres out of the ten showed a statistically significant reduction in mortality in patients receiving SDD versus control. A recent French study describes the eradication of an outbreak of a multi-resistantKlebsiella with SDD. The Paris trial suggests a major impact of the SDD maneuver on the ICU ecology. Emergence of resistance to the SDD agents among gram-positive cocci has been described, although the clinical impact of this antibiotic side effect has not been reported so far. There are three indications for SDD, as follows: (i) trauma patients; (ii) liver transplant recipients and (iii) outbreaks of multi-resistant organisms.
Zusammenfassung
Übersicht über publizierte Studien. Bisher wurden 18 Studien über selektive Darmdekontamination (SDD) publiziert. In 14 der 15 unter kontrollierten Bedingungen durchgeführten Untersuchungen wurde eine statistisch signifikante Reduktion der Infektionsraten gefunden. Obwohl sämtliche Studien die Feststellung der infektionsbezogenen Morbidität zum Ziel hatten, wurden von zehn Zentren Mortalitätsraten mitgeteilt. In sechs dieser zehn Publikationen wurde eine statistisch signifikante Abnahme der Mortalität nachgewiesen. Eine kürzlich veröffentlichte französische Arbeit beschreibt die Kontrolle einer Endemie mit multiresistentenKlebsiella spp. mittels SDD. Das Ergebnis dieser Pariser Studie ist möglicherweise die Folge einer klinisch relevanten Beeinflussung der Mikroflora auf der Intensivtherapiestation durch SDD. Unter SDD sind Resistenzentwicklungen von grampositiven Kokken beschrieben worden; über die klinische Bedeutung dieses Phänomens wurde jedoch nicht berichtet. Es existieren drei Indikationen für SDD: 1. polytraumatisierte Patienten; 2. lebertransplantierte Patienten; 3. Endemien mit multiresistenten Mikroorganismen.
Similar content being viewed by others
References
van Saene, H. K. F., Stoutenbeek, C., P., Zandstra, D. F.: Concept of selective decontamination of the digestive tract in the critically ill. In:van Saene, H. K. F., Stoutenbeek, C. P., Lawin, P., McA. Ledingham, I. (eds.): Infection control by selective decontamination. Springer Verlag 1989, pp. 88–94.
van Saene, H. K. F., Stoutenbeek, C. P., Stoller, J. K.: Selective decontamination of the digestive tract (SDD) in ICU: Current status and future prospects. Crit. Care Med. (1990) in press.
Guiot, H. F. L., van der Meer, J. W. M., van Furth, R. Selective antimicrobial modulation of human microbial flora: infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria. J. Infect. Dis. 143 (1981) 644–654.
van Saene, J. J. M., van Saene, H. K. F., Stoutenbeek, C. P., Lerk, C. F. Influence of faeces on the activity of antimicrobial agents used for decontamination of the alimentary canal. Scand. J. Infect. Dis. 17 (1985) 295–300.
van Saene, J. J. M., van Saene, H. K. F., Tarko-Smith, N. J. Ph., Beukeveld, G. J. J. Enterobacteriaceae suppression by three different oral doses of polymyxin E in human volunteers. Epidem. Infect. 100 (1988) 407–417.
Carlet, J.: Consensus Confrence Paris. Diagnostic des pneumopathies nosocomiales en réanimation. Réanimation Soins Intensifs Médicine d'Urgence (1990) in press.
Stoutenbeek, C. P., van Saene, H. K. F., Miranda, D. R., Zandstra, D. F., Langrehr, D. The effect of oropharyngeal decontamination using topical non-absorbable antibiotics on the incidence of nosocomial respiratory tract infections in multiple trauma patients. J. Trauma 27 (1987) 357–364.
Huxley Miller, E., Caplan, E. S. Nosocomial hemophilus pneumonia in patients with severe trauma. Surg. Gynecol. Obstet. 159 (1984) 153–156.
Weinstein, L., Goldfield, M., Chang, T. W. Infection occurring during chemotherapy. A study of their frequency, type and predisposing factors. N. Engl. J. Med. 251 (1954) 247–255.
Stoutenbeek, C. P., van Saene, H. K. F., Miranda, D. R., Zandstra, D. F., Binnendijk, B. The prevention of superinfection in multiple trauma patients. J. Antimicrob. Chemother. 14 (Suppl. B) (1984) 203–211.
Stoutenbeek, C. P., van Saene, H. K. F.: How to improve infection prevention by selective decontamination of the digestive tract (SDD). Infection (this issue) (1990).
Retailliau, H. F., Hightower, A. W., Dixon, R. E., Allen, J. R. Acinetobacter calcoaceticus: a nosocomial pathogen with an unusual seasonal pattern. J. Infect. Dis. 139 (1979) 371–375.
Tullus, K., Burman, L. G. Ecological impact of ampicillin and cefuroxime in neonatal units. Lancet i (1989) 1405–1407.
Kerver, A. J. H., Rommes, J. H., Mevissen-Verhage, E. A. E., Hulstaert, P. F., Vos, A., Verhoef, J. Colonization and infection in surgical intensive care patients — a prospective study. Intensive Care Med. 13 (1987) 347–351.
Gross, P. A., van Antwerpen, C. Nosocomial infections and hospital deaths. A case control study. Amer. J. Med. 75 (1983) 658–662.
Dekker, A. W., Rozenberg-Arska, M., Sixma, J. J., Verhoef, J. Prevention of infection by trimethoprim — sulfamethoxazole plus amphotericin B in patients with acute non lymphoblastic leukaemia. Ann. Intern. Med. 95 (1981) 555–559.
Lacroix, J., Infante-Rivard, C., Jenicek, M., Gauthier, M. Prophylaxis of upper gastrointestinal bleeding in intensive care units: A meta-analysis. Crit. Care Med. 17 (1989) 862–869.
Feeley, T. W., du Moulin, G. C., Hedley-Whyte, J., Bushnell, L. S., Gilbert, J. P., Feingold, D. S. Aerosol polymyxin and pneumonia in seriously ill patients. N. Engl. J. Med. 293 (1975) 471–475.
Weinstein, R. A. Selective intestinal decontamination — an infection control measure whose time has come? Ann. Intern. Med. 110 (1989) 853–854.
Daschner, F. Selektive Dekontamination auf Intensivstationen? Der Anästhesist 36 (1987) 696–697.
Daschner, F. Cefotaxim-Resistenz bei selektiver Dekontamination des Verdauungstraktes. Arznei Telegramm 5 (1989) 49–50.
Kappstein, I., Daschner, F. Resistenzentwicklung bei selektiver Darmdekontamination. Deutsches Ärzteblatt 41 (1989) 2073–2074.
Langer, M., Mosconi, P., Cigada, M., Mandelli, M., andICU group of infection control Long-term respiratory support and risk of pneumonia in critically ill patients. Am. Rev. Resp. Dis. 140 (1984) 302–305.
van Saene, H. K. F., Stoutenbeek, C. P., Zandstra, D. F. Cefotaxime combined with selective decontamination in long-term intensive care unit patients. Virtual absence of emergence of resistance. Drugs 35 (Suppl. 2) (1988) 29–34.
Daschner, F. Cost-effectiveness in hospital infection control. Lessons for the 1990s. J. Hosp. Inf. 13 (1989) 325–326.
Craven, D. E., Daschner, F. D. Nosocomial pneumonia in the intubated patient: role of gastric colonization. Eur. J. Clin. Microbiol. and Infect. Dis. 8 (1989) 40–50.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Saene, H.K.F., Stoutenbeek, C.P. & Gilbertson, A.A. Review of available trials of selective decontamination of the digestive tract (SDD). Infection 18 (Suppl 1), S5–S9 (1990). https://doi.org/10.1007/BF01644479
Issue Date:
DOI: https://doi.org/10.1007/BF01644479